Article Text

Download PDFPDF

825 α-CD38 therapy reverses α-PD1 resistance when used in a proper biologic schedule; explaining and overcoming previous failures of the combination in clinical trials

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.